Clinical Trials
14 trialsNCT03093116 2026-05-27
TRIDENT-1
Turning Point Therapeutics, Inc.
Phase 1/2 Recruiting
NCT06012435 2026-05-27
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Seagen Inc.
Phase 3 Active not recruiting
NCT00001465 2026-05-22
Study of the Disease Process of Lymphangioleiomyomatosis
National Institutes of Health Clinical Center (CC)
Recruiting
NCT00001532 2026-05-22
Role of Genetic Factors in the Development of Lung Disease
National Institutes of Health Clinical Center (CC)
Recruiting
NCT07455552 2026-05-22
Smartphone-based Telerehabilitation Versus Home-based Inspiratory Muscle Training After Lung Resection in High-risk Patients
Pusan National University Hospital
Phase NA Completed
NCT06119581 2026-05-19
SUNRAY-01
Eli Lilly and Company
Phase 3 Recruiting
NCT06376084 2026-05-19
FOREFRONT
AstraZeneca
Active not recruiting
NCT06431633 2026-05-18
ARIAN
Fundación GECP
Phase 3 Recruiting
NCT00534690 2026-05-15
REVOLU
University Hospital, Bordeaux
Phase NA Completed
NCT05462717 2026-05-15
Dose Escalation and Dose Expansion Study of RMC-6291 Monotherapy in Subjects With Advanced KRASG12C Mutant Solid Tumors
Revolution Medicines, Inc.
Phase 1 Active not recruiting
NCT06606847 2026-05-15
LADOGA
AstraZeneca
Phase 2 Active not recruiting
NCT06765109 2026-05-14
ALKAZAR
Nuvalent Inc.
Phase 3 Recruiting
NCT04564157 2026-05-05
NADIM-ADJUVANT
Fundación GECP
Phase 3 Active not recruiting
NCT05012254 2026-05-05
NIVIPI-Brain
Fundación GECP
Phase 2 Active not recruiting